ArticleChemSusChem2025
Engineering Lignin-Based Tubular Hydrogel Scaffolds for Load-Bearing Biomedical Applications.
Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engineering Lignin-Based Tubular Hydrogel Scaffolds for Load-Bearing Biomedical Applications.ChemSusChem · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The development of mechanically robust, biocompatible, and biodegradable hydrogels remains a significant challenge for biomedical applications involving load-bearing soft tissues. Herein, a tubular lignin-derived hydrogel is engineered to assess its physicochemical, mechanical, and biological properties. Kraft and organosolv lignin are systematically compared at varying crosslinker concentrations to determine their effect on pore morphology, swelling behavior, and mechanical performance. Organosolv lignin formulations at 5% crosslinker concentration demonstrate an optimal balance between strength (ultimate tensile strength: 83.14 ± 0.16 kPa), flexibility (elongation: up to 176%), and hydration (swelling capacity: 261%), and are further fabricated into tubular geometries, with and without polypropylene mesh reinforcement. The reinforced tubular constructs exhibit superior mechanical strength, sustained performance over 100 fatigue cycles, and cytocompatibility with fibroblast cultures (cell viability: 85.5-86.5% after 96 h). These findings highlight the potential of lignin-based hydrogel scaffolds as sustainable, tunable platforms for a broad range of biomedical applications requiring soft, mechanically resilient, and tubular structures, such as tendon repair, vascular conduits, and nerve regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.